Diagnostic protein marker patterns in squamous cervical cancer

Proteomics - Clinical Applications

Volumn 4, Issue 1, 2010, Pages 17-31

  Lomnytska, Marta I ^a,b   Becker, Susanne ^a   Hellman, Kristina ^a   Hellström, Ann Cathrin ^a   Souchelnytskyi, Serhiy ^a   Mints, Miriam ^a   Hellman, Ulf ^c   Andersson, Sonia ^a   Auer, Gert ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Diagnostics; Markers; Protein patterns; Squamous cervical cancer

Indexed keywords

ACTIN RELATED PROTEIN 2; ACTIN RELATED PROTEIN 3; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 5; APOLIPOPROTEIN E; CALPHOBINDIN II; CATHEPSIN D; CYTOKERATIN 13; ELONGATION FACTOR 1; EXTRACELLULAR SUPEROXIDE DISMUTASE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; INITIATION FACTOR 3; LUMICAN; MIMECAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; NEUTROPHIL CYTOSOLIC FACTOR 2; PEROXIREDOXIN 2; PEROXIREDOXIN 4; PHOSPHOGLUCOMUTASE; PLAKOGLOBIN; PYRUVATE KINASE; RAB PROTEIN; RAB2A PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SERINE PROTEINASE INHIBITOR; STRATIFIN; TRANSALDOLASE; TROPOMYOSIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL ELECTROPHORESIS; UNINDEXED SEQUENCE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX MUCOSA; VAGINA CANCER; VAGINA MUCOSA;

ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS, SQUAMOUS CELL; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EUKARYOTA; SPRING VIREMIA OF CARP VIRUS;

EID: 77951741397     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900086     Document Type: Article

References (42)

1. Garcia, M., Lemal, A., Ward, E.M., Center, M.M. et al., Global Cancer Facts and Figures. American Cancer Society, Atlanta, GA 2007.
2. Zur Hausen, H., Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009, 384, 260-265.
3. Castellsagu, X., Natural history and epidemiology of HPV infection and cervical cancer. Gynecol. Oncol. 2008, 110, S4-7.
4. Simen-Kapeu, A., Kataja, V., Yliskoski, M., Syrjänen, K. et al., Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scand. J. Infect. Dis. 2008, 40, 745-751.
5. Wang, S.S., Zuna, R.E., Wentzensen, N., Dunn, S.T. et al., Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 113-120.
6. Gunnell, A.S., Tran, T.N., Torrång, A., Dickman, P.W. et al., Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 2141-2147.
7. Jeon, J.H., Shin, D.M., Cho, S.Y., Song, K.Y. et al., Immunocytochemical detection of HPV16 E7 in cervical smear. Exp. Mol. Med. 2007, 39, 621-628.
8. Bofin, A.M., Nygård, J. F., Skare, G.B., Dybdahl, B.M. et al., Papanicolaou smear history in women with low-grade cytology before cervical cancer diagnosis. Cancer 2007, 111, 210-216.
9. Khuakoonratt, N., Tangjitgamol, S., Manusirivithaya, S., Khunnarong, J. et al., Prevalence of high grade squamous intraepithelial lesion (HSIL) and invasive cervical cancer in patients with low grade squamous intraepithelial lesion (LSIL) at cervical pap smear. Asian Pac. J. Cancer Prev. 2008, 9, 253-257.
10. Kalir, T., Simsir, A., Demopoulos, H.B., Demopoulos, R.I., Obstacles to the early detection of endocervical adenocarcinoma. Int. J. Gynecol. Pathol. 2005, 24, 399-403.
11. Gunnell, A.S., Ylitalo, N., Sandin, S., Sparén, P. et al., A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 2641-2648.
12. Cárdenas-Turanzas, M., Follen, M., Nogueras-Gonzalez, G.M., Benedet, J.L. et al., The accuracy of the Papanicolaou smear in the screening and diagnostic settings. J. Low Genit. Tract Dis. 2008, 12, 269-275.
13. Kirschner, B., Simonsen, K., Junge, J., Comparison of conventional Papanicolaou smear and SurePath liquid-based cytology in the Copenhagen population screening programme for cervical cancer. Cytopathology 2006, 17, 187-194.
14. Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X. et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189, 12-19.
15. Kulasingam, V., Diamandis, E.P., Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat. Clin. Pract. Oncol. 2008, 5, 588-599.
16. Bae, S.M., Lee, C.H., Cho, Y.L., Nam, K.H. et al., Twodimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol. Oncol. 2005, 99, 26-35.
17. Choi, Y.P., Kang, S., Hong, S., Xie, X. et al., Proteomic analysis of progressive factors in uterine cervical cancer. Proteomics 2005, 5, 1481-1493.
18. Zhu, X., Lv, J., Yu, L., Zhu, X. et al., Proteomic identification of differentially-expressed proteins in squamous cervical cancer. Gynecol. Oncol. 2009, 112, 248-256.
19. Hellman, K., Alaiya, A.A., Schedvins, K., Steinberg, W. et al., Protein expression patterns in primary carcinoma of the vagina. Br. J. Cancer 2004, 91, 319-326.
20. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
21. Lomnytska, M., Dubrovska, A., Hellman, U., Volodko, N. et al., Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients. Int. J. Cancer. 2006, 118, 412-421.
22. Cheng, A.L., Huang, W.G., Chen, Z.C., Zhang, P.F. et al., Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J. Proteome Res. 2008, 7, 2415-2426.
23. Glantz, S., Medico-biological Statistics. Medicyna Praktika, Moscow 1998.
24. Petrak, J., Ivanek, R., Toman, O., Cmejla, R. et al., Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8, 1744-1749.
25. Pontén, F., Jirström, K., Uhlen, M., The Human Protein Atlas-a tool for pathology. J. Pathol. 2008, 216, 387-393.
26. Rodríguez-Pérez, M. A., Medina-Aunon, A., Encarnación-Guevara, S.M., Bernal-Silvia, S. et al., In silico analysis of protein neoplastic biomarkers for cervix and uterine cancer. Clin. Transl. Oncol. 2008, 10, 604-617.
27. Barth, P.J., Koch, S., M. uller, B., Unterstab, F. et al., Proliferation and number of Clara cell 10-kDa protein (cc10)-reactive epithelial cells and basal cells in normal, hyperplastic and metaplastic bronchial mucosa. Virchows Arch. 2000, 437, 648-655.
28. Celis, J.E., Celis, P., Palsdottir, H., Østergaard, M. et al., Proteomic strategies to reveal tumor heterogeneity among urothelial papillomas. Mol. Cell. Proteomics 2002, 1, 269-279.
29. Downey, P., Cummins, R., Moran, M., Gulmann, C., If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung. APMIS 2008, 116, 526-529.
30. Chapman-Fredricks, J., Jorda, M., Gomez-Fernandez, C., A limited immunohistochemical panel helps differentiate small cell epithelial malignancies of the sinonasal cavity and nasopharynx. Appl. Immunohistochem. Mol. Morphol. 2009, 17, 207-210.
31. Gerke, V., Moss, S.E., Annexins: from structure to function. Physiol. Rev. 2002, 82, 331-371.
32. Francia, G., Mitchell, S.D., Moss, S.E., Hanby, A.M. et al., Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res. 1996, 56, 3855-3858.
33. Schremmer, B., Manevich, Y., Feinstein, S.I., Fisher, A.B., Peroxiredoxins in the lung with emphasis on peroxiredoxin VI. Subcell. Biochem. 2007, 44, 317-344.
34. Jara, M., Vivancos, A.P., Hidalgo, E., C-terminal truncation of the peroxiredoxin Tpx1 decreases its sensitivity for hydrogen peroxide without compromising its role in signal transduction. Genes Cells 2008, 13, 171-179.
35. Jönsson, T. J., Johnson, L.C., Lowther, W.T., Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace. Nature 2008, 451, 98-101.
36. Smith-Pearson, P.S., Kooshki, M., Spitz, D.R., Poole, L.B. et al., Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic. Biol. Med. 2008, 45, 1178-1189.
37. Swallow, C.J., Partridge, E.A., Macmillan, J.C., Tajirian, T. et al., Alpha-2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression. Cancer Res. 2004, 64, 6402-6409.
38. Petrik, V., Saadoun, S., Loosemore, A., Hobbs, J. et al., Serum alpha-2HS-glycoprotein predicts survival in patients with glioblastoma. Clin. Chem. 2008, 54, 713-722.
39. Cui, X., Song, B., Hou, L., Wei,.Z., Tang, J., High expression of osteoglycin decreases the metastatic capability of mouse hepatocarcinoma Hca-F cells to lymph nodes. Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40, 349-355.
40. Kim, S.H., Kim, M.O., Gao, P., Youm, C.A. et al., Overexpression of extracellular superoxide dismutase (EC-SOD) in mouse skin plays a protective role in DMBA/TPA-induced tumor formation. Oncol. Res. 2005, 15, 333-341.
41. Soini, Y., Kallio, J.P., Hirvikoski, P., Helin, H. et al., Antioxidant enzymes in renal cell carcinoma. Histol. Histopathol. 2006, 21, 157-165.
42. Chiba, T., Yokosuka, O., Fukai, K., Kojima, H. et al., Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells. Oncology 2004, 66, 481-491.